JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopin, I. J.
Right arrow Articles by Weise, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopin, I. J.
Right arrow Articles by Weise, V. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 2, 271-278, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


SELECTIVE RELEASE OF NEWLY SYNTHESIZED NOREPINEPHRINE FROM THE CAT SPLEEN DURING SYMPATHETIC NERVE STIMULATION

Irwin J. Kopin 1, George R. Breese 1, Kenneth R. Krauss 1, and Virginia K. Weise 1

1 Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland

During perfusion with tyrosine-C14-containing solution, norepinephrine-C14 is synthesized in the cat spleen. Rapid nerve stimulation results in release of norepinephrine-C14 having a greater specific activity than that found in the spleen, indicating that the newly synthesized norepinephrine is selectively released. When spleens from cats which had been treated with norepinephrine-H3 were perfused, the specific activity of norepinephrine released initially was similar to that in the spleen. After a period of continuous nerve stimulation, however, when the immediately available stores were depleted, the specific activity fell to about one-third that found in the spleen. If the perfusing solution contained agr-methyltyrosine, an inhibitor of norepinephrine synthesis, initial release was not altered. At later times, however, only about one-third as much norepinephrine was released and the specific activity of the released catecholamine was similar to that in the spleen. These results suggest that, during continued rapid stimulation, mobilization of stored norepinephrine does not play as great a role in maintenance of transmitter release as does new synthesis.

Submitted on December 15, 1967
Accepted on February 22, 1968




This article has been cited by other articles:


Home page
Clin. Chem.Home page
D. S. Goldstein and C. Holmes
Neuronal Source of Plasma Dopamine
Clin. Chem., November 1, 2008; 54(11): 1864 - 1871.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Tsudzuki
Isolation of Small Agranular Synaptic Vesicles of Rat Brain by Gel Filtration Chromatography
J. Biochem., April 1, 2003; 133(4): 437 - 443.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
W. Betz and G. Bewick
Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction
Science, January 10, 1992; 255(5041): 200 - 203.
[Abstract] [PDF]


Home page
ScienceHome page
P. Skolnick and J. W. Daly
Norepinephrine-Sensitive Adenylate Cyclases in Rat Brain: Relation to Behavior and Tyrosine Hydroxylase
Science, April 12, 1974; 184(4133): 175 - 177.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Mendels and A. Frazer
Brain Biogenic Amine Depletion and Mood
Arch Gen Psychiatry, April 1, 1974; 30(4): 447 - 451.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
W. E. Bunney Jr., F. K. Goodwin, and D. L. Murphy
The "Switch Process" in Manic-Depressive Illness: III. Theoretical Implications
Arch Gen Psychiatry, September 1, 1972; 27(3): 312 - 317.
[Abstract] [PDF]


Home page
ScienceHome page
S. H. Koslow, F. Cattabeni, and E. Costa
Norepinephrine and Dopamine: Assay by Mass Fragmentography in the Picomole Range
Science, April 14, 1972; 176(4031): 177 - 180.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. L. Dunner, C. K. Cohn, E. S. Gershon, and F. K. Goodwin
Differential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness
Arch Gen Psychiatry, October 1, 1971; 25(4): 348 - 353.
[Abstract] [PDF]


Home page
ScienceHome page
D. S. Segal, J. L. Sullivan III, R. T. Kuczenski, and A. J. Mandell
Effects of Long-Term Reserpine Treatment on Brain Tyrosine Hydroxylase and Behavioral Activity
Science, August 27, 1971; 173(3999): 847 - 849.
[Abstract] [PDF]


Home page
ScienceHome page
J. J. Schildkraut, P. R. Draskoczy, and P. S. Lo
Norepinephrine Pools in Rat Brain: Differences in Turnover Rates and Pathways of Metabolism
Science, May 7, 1971; 172(3983): 587 - 589.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. J. Reis, D. T. Moorhead II, and N. Merlino
Dopa-Induced Excitement in the Cat: Its Relationship to Brain Norepinephrine Concentrations
Arch Neurol, January 1, 1970; 22(1): 31 - 39.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.